Inadequacy of vaccines to combat increasing rare infectious diseases in livestock and companion animals is the key driving factor aiding the growth of the autogenous vaccines market.
Autogenous vaccines are an efficient alternative to antibiotics that control and prevent infectious diseases. Improvements in animal health, decreased animal suffering, efficient food production, and reduction in the need for antibiotics are boosting the adoption of autogenous vaccines in the livestock industry.
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/29491
Gain More Insights about this Report
Company Profiles
Increasing animal care spending and research & development activities in the veterinary biologics sector further favours the growth of the autogenous vaccines market.
The global autogenous vaccines market was valued at US$ 428 Mn in 2018, and is expected to witness a CAGR of 4.4% over the forecast period (2019–2029).
Key Takeaways of Autogenous Vaccines Market Study
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/29491
“Unavailability of licensed vaccines for bacterial and viral infections in animals has directed the focus of several small & large manufactures to invest in the manufacturing of autogenous vaccines, thereby propelling the growth of the autogenous vaccines market,” says a PMR analyst.
Product Portfolio Expansion through Partnerships – Key Strategy of Leading Autogenous Vaccine Manufacturers
Autogenous vaccine manufacturers are focusing on product portfolio expansion through partnerships with and acquisition of small veterinary biologics manufactures.
For example, in 2018, Huvepharma acquired AgriLabs, to expand its presence in the U.S. and speed up the commercialization of biologic products for animal health. The acquisition included AgriLabs’s custom vaccines business.
Moreover, in 2017, Pharmgate and Cambridge Technologies entered into a strategic alliance to provide commercial, autogenous, and prescription vaccine solutions to veterinarians.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/29491
More Valuable Insights on Autogenous Vaccines Market
Persistence Market Research offers a unique perspective and actionable insights on autogenous vaccines in its latest study, presenting historical demand assessment from 2014–2018 and projections for 2019–2029, on the basis of strain type (bacterial strain and virus strain), and end user (veterinary clinics, veterinary hospitals, and veterinary research institutes), across seven major regions.
Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape
Ophthalmology devises Market –
Ophthalmology devises Market Segmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.
Intravenous Iron Drugs Market –
Intravenous (IV) Iron Drugs Market Segmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A/S, Rockwell Medical Technologies, Inc., and Sanofi.
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
U.S. Phone - +1-646-568-7751
U.S.-Canada Toll-free : +1 800-961-0353
E-mail id - sales@persistencemarketresearch.com
Website : www.persistencemarketresearch.com